{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:04:06Z","timestamp":1784221446346,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arcmed.2026.103430","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:02:10Z","timestamp":1777125730000},"page":"103430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factor XII Deficiency and Thrombosis Risk: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-6855","authenticated-orcid":false,"given":"Maximiliano Correa","family":"Lara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6205-4651","authenticated-orcid":false,"given":"Jaime","family":"Garc\u00eda Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Martinez","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2026.103430_bib0001","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","article-title":"Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis and thrombosis","volume":"125","author":"Stavrou","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2026.103430_bib0002","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/asheducation-2014.1.66","article-title":"Epidemiologic and clinical data linking factors XI and XII to thrombosis","volume":"2014","author":"Key","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.arcmed.2026.103430_bib0003","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2026.103430_bib0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renn\u00e9","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2026.103430_bib0005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2007.02530.x","article-title":"Evidence of a U-shaped association between factor XII activity and overall survival","volume":"5","author":"Endler","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2026.103430_bib0006","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJM196810032791407","article-title":"The demise of John Hageman","volume":"279","author":"Ratnoff","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2026.103430_bib0007","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00005792-198307000-00004","article-title":"Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias","volume":"62","author":"Goodnough","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcmed.2026.103430_bib0008","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.arcmed.2026.103430_bib0009","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1538-7836.2007.02446.x","article-title":"The intrinsic pathway of coagulation: a target for treating thromboembolic disease?","volume":"5","author":"Gailani","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2026.103430_bib0010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1160\/TH03-10-0620","article-title":"Homozygosity for the 46C\u2192T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis","volume":"91","author":"Tirado","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arcmed.2026.103430_bib0011","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arcmed.2026.103430_bib0012","series-title":"Cochrane handbook for systematic reviews of interventions","first-page":"187","article-title":"Assessing risk of bias in included studies","author":"Higgins","year":"2008"},{"key":"10.1016\/j.arcmed.2026.103430_bib0013","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.arcmed.2026.103430_bib0014","doi-asserted-by":"crossref","DOI":"10.2196\/64016","article-title":"MetaAnalysisOnline.com: web-based tool for the rapid meta-analysis of clinical and epidemiological studies","volume":"27","author":"Fekete","year":"2025","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.arcmed.2026.103430_bib0015","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1177\/21925682221110527","article-title":"Fixed-effect vs random-effects models for meta-analysis: three points to consider","volume":"12","author":"Dettori","year":"2022","journal-title":"Global Spine J"},{"key":"10.1016\/j.arcmed.2026.103430_bib0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.arcmed.2026.103430_bib0017","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1474515120944014","article-title":"Meta-analysis: how to quantify and explain heterogeneity?","volume":"19","author":"Ruppar","year":"2020","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.arcmed.2026.103430_bib0018","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.arcmed.2026.103430_bib0019","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"10.1016\/j.arcmed.2026.103430_bib0020","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.arcmed.2026.103430_bib0021","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jrsm.1404","article-title":"Methods for estimating between-study variance in meta-analysis of odds ratios","volume":"11","author":"Bakbergenuly","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.arcmed.2026.103430_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2023.102913","article-title":"Factor XII deficiency in Mexico","volume":"55","author":"Dominguez-Reyes","year":"2024","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2026.103430_bib0023","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2141.1994.tb04937.x","article-title":"John Hageman's factor and deep-vein thrombosis","volume":"87","author":"Koster","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2026.103430_bib0024","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2004.05.005","article-title":"Plasma levels of factor XII in venous thrombosis","volume":"114","author":"Gallimore","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2026.103430_bib0025","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2009-05-219915","article-title":"Coagulation factors IX\u2013XIII and venous thrombosis risk","volume":"114","author":"Cushman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2026.103430_bib0026","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","article-title":"Factors XI and XII and myocardial infarction risk","volume":"108","author":"Doggen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2026.103430_bib0027","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0043-1769509","article-title":"Factor XII structure\u2013function relationships","volume":"50","author":"Shamanaev","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.arcmed.2026.103430_bib0028","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-0036-1598003","article-title":"Factor XII contact activation","volume":"43","author":"Naudin","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.arcmed.2026.103430_bib0029","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3389\/fimmu.2019.02011","article-title":"Roles of factor XII in innate immunity","volume":"10","author":"Renn\u00e9","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2026.103430_bib0030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets in venous thrombosis","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2026.103430_bib0031","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1301059110","article-title":"Neutrophil histone modification and DVT","volume":"110","author":"Martinod","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2026.103430_bib0032","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2026.103430_bib0033","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1538-7836.2007.02687.x","article-title":"Plasma kallikrein-kinin system and cardiovascular risk","volume":"5","author":"Govers-Riemslag","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2026.103430_bib0034","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/CIRCULATIONAHA.110.943738","article-title":"Intrinsic coagulation and arterial thrombosis","volume":"122","author":"Siegerink","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2026.103430_bib0035","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.102.23.2816","article-title":"Hemostatic factors and coronary heart disease","volume":"102","author":"Cooper","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2026.103430_bib0036","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1365-2141.2000.02251.x","article-title":"Reduced factor XII levels in antiphospholipid syndrome","volume":"110","author":"Jones","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2026.103430_bib0037","first-page":"474","article-title":"Clinical development of anti-FXII therapeutics","volume":"45","author":"Mu\u00f1oz","year":"2024","journal-title":"Rev Med Interne"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440926000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440926000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:12:50Z","timestamp":1784218370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440926000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0188440926000536"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103430","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor XII Deficiency and Thrombosis Risk: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103430"}}